| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.3 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |